Search Results Search Sort by RelevanceMost Recent Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105. Viewpoint Jun 2012 What Can Physicians Learn from the Neurodiversity Movement? Christina Nicolaidis, MD, MPH The neurodiversity movement challenges us to rethink autism through the lens of human diversity, valuing diversity in neurobiologic development as we would value it in gender, race, ethnicity, religion, or sexual orientation. Virtual Mentor. 2012;14(6):503-510. doi: 10.1001/virtualmentor.2012.14.6.oped1-1206. State of the Art and Science Oct 2019 Should Clinicians Leave “Expanded” Carrier Screening Decisions to Patients? Amanda Fakih, MHSA and Kayte Spector-Bagdady, JD, MBE Testing everyone for everything identifies more fetal conditions, but confusion persists about whether clinicians should leave screening decisions to patients. AMA J Ethics. 2019;21(10):E858-864. doi: 10.1001/amajethics.2019.858.